Latest / Making it in Manufacturing
CPHI Milan 2026 Newsbeat: AI's $30m Yield Boost In Pharma Manufacturing - Pep Gubau
For Pep Gubau, AI is ready for pharma manufacturing, and the results are already measurable: one of Aizon's early adopters, a plasma derivatives manufacturer, raised its yield by 4% in three months, worth $30 million. This year CPHI gave AI a dedicated zone of its own.
On Newsbeat, live at CPHI Milan 2026, Ruby Collier spoke to Pep Gubau, CEO and Founder of Aizon, about where AI is delivering results in pharma manufacturing.
In this episode, Pep covers:
(00:31) What a dedicated AI zone at CPHI means to a company that has focused on AI for pharma manufacturing for more than 12 years, and the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.